glucagon has been researched along with thiazolidines in 5 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (thiazolidines) | Trials (thiazolidines) | Recent Studies (post-2010) (thiazolidines) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 3,544 | 160 | 1,407 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hotta, N; Koh, N; Sakakibara, F; Sakamoto, N | 1 |
| Chan, O; D'Agostino, G; Diano, S; DiLeone, RJ; Elsworth, JD; Harvey, BK; Jeong, JK; Kibbey, RG; Kim, JD; Myöhänen, T; Richie, CT; Savolainen, M; Toda, C; Zeiss, CJ | 1 |
| Nakamura, S; Nakazato, M; Sakoda, H; Tsubouchi, C; Tsuchimochi, W; Ueno, H; Yamashita, E | 1 |
| Kondo, Y; Mitsumatsu, T; Okahata, S; Sakamoto, K; Shiba, T; Tanaka, S | 1 |
| Fushimi, Y; Hirukawa, H; Horiya, M; Iwamoto, Y; Kaku, K; Kan, Y; Kaneto, H; Kinoshita, T; Kohara, K; Mashiko, A; Mizoguchi-Tomita, A; Mune, T; Nakanishi, S; Nishioka, M; Obata, A; Okauchi, S; Sanada, J; Shimoda, M; Tatsumi, F | 1 |
1 trial(s) available for glucagon and thiazolidines
| Article | Year |
|---|---|
Mechanistic insights from sequential combination therapy with a sodium glucose co-transporter-2 inhibitor and a dipeptidyl peptidase-4 inhibitor: Results from the CANARIS Trial using canagliflozin and teneligliptin.
Topics: Adult; Aged; Blood Glucose; Canagliflozin; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pyrazoles; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidines | 2019 |
4 other study(ies) available for glucagon and thiazolidines
| Article | Year |
|---|---|
Effects of high glucose concentrations and epalrestat on sorbitol and myo-inositol metabolism in cultured rabbit aortic smooth muscle cells.
Topics: Aldehyde Reductase; Animals; Aorta; Biological Transport, Active; Cells, Cultured; Cytochalasin B; Dose-Response Relationship, Drug; Fructose; Glucagon; Glucose; Inositol; Insulin; Muscle, Smooth, Vascular; Ouabain; Rabbits; Rhodanine; Sodium; Sorbitol; Thiazolidines | 1993 |
Hypothalamic prolyl endopeptidase (PREP) regulates pancreatic insulin and glucagon secretion in mice.
Topics: Animals; Blood Glucose; Gene Expression; Gene Knockdown Techniques; Glucagon; Glucose Clamp Technique; Glucose Intolerance; Hypothalamus; Indoles; Insulin; Insulin Secretion; Ion Channels; Male; Mice; Mice, Transgenic; Mitochondrial Proteins; Pancreas; Phosphorylation; Prolyl Oligopeptidases; Receptor, Insulin; Recombinant Proteins; Serine Endopeptidases; Serine Proteinase Inhibitors; Thiazolidines; Uncoupling Protein 1; Ventromedial Hypothalamic Nucleus | 2014 |
Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Topics: Aged; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Japan; Middle Aged; Monitoring, Ambulatory; Postprandial Period; Pyrazoles; Thiazolidines | 2015 |
Effect of Combination Therapy of Canagliflozin Added to Teneligliptin Monotherapy in Japanese Subjects with Type 2 Diabetes Mellitus: A Retrospective Study.
Topics: Aged; Blood Glucose; Canagliflozin; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Japan; Male; Middle Aged; Pyrazoles; Retrospective Studies; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidines; Treatment Outcome | 2020 |